间隔消融术对比心肌切除术治疗梗阻性肥厚型心肌病研究进展

Progress in Comparison of Percutaneous Transluminal Septal Myocardial Ablation versus Septal Myectomy for Treatment of Patients with Hypertrophic Obstructive Cardiomyopathy

先前认为室间隔心肌部分切除术是治疗药物难治性梗阻性肥厚型心肌病的金标准,近年来,经皮经腔间隔心肌消融术由于创伤小,操作简单,获得广泛开展并取得了较好的疗效。但究竟哪种是更好的治疗方法,一直存在争论。现就目前药物难治性梗阻性肥厚型心肌病的两种方法疗效比较作一综述。

Septal myectomy（SM） was previously been regarded as the primary treatment for drug refractory hypertrophic obstructive cardiomyopathy.However,the emerging,less invasive and easier to perform,percutaneous transluminal septal myocardial ablation（PTSMA） has recently been accepted as an effective intervention.There is still a debate as to which treatment is the preferred option.This article is a review of progress made on the comparison of the efficacy of PTSMA versus SM.